MetLife Q4 Earnings Beat Estimates on Increasing Volumes
zacks.com
Want to monitor ARAV?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor ARAVversartis, inc. (nasdaq: vsar) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. the company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry.